| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992517 | Journal of Thoracic Oncology | 2006 | 8 Pages |
Abstract
Sequential vinorelbine and docetaxel is a well-tolerated and effective regimen in comparison with reports of other treatments tested in patients with advanced NSCLC age 70 and older and/or with a PS of 2.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Paul J. MD, Kari PhD, Derick H.M. MD, James H. MD, Carol M. PhD, Robert A. MD, J Wendall MD, Howard M. MD, John J. PhD, David R. MD,